CIBC Private Wealth Group
CLSD

CIBC Private Wealth Group’s Clearside Biomedical CLSD Stock Holding History

CIBC Private Wealth Group’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-73
Closed -$290 – 3418
2025
Q3 		$290 Hold
73
– – ﹤0.01% 2918
2025
Q2 		$880 Hold
73
– – ﹤0.01% 2778
2025
Q1 		$901 Hold
73
– – ﹤0.01% 2825
2024
Q4 		$1.07K Hold
73
– – ﹤0.01% 2790
2024
Q3 		$1.4K Hold
73
– – ﹤0.01% 2864
2024
Q2 		$1.38K Hold
73
– – ﹤0.01% 2837
2024
Q1 		$1.74K Buy
+73
New +$1.57K ﹤0.01% 2777

Other funds holding CLSD

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

CIBC Private Wealth Group's CLSD Position: Q4 2025 in Review

CIBC Private Wealth Group sold out of Clearside Biomedical (CLSD) in Q4 2025, closing a stake of 73 shares — an estimated $290 sold.

CIBC Private Wealth Group first reported a position in CLSD in Q1 2024 and held it in 7 quarters. The position peaked at $1.74K in Q1 2024. 1 fund tracked by Wall St. Rank holds CLSD as of Q4 2025.

  • CIBC Private Wealth Group reported no remaining Clearside Biomedical position as of Q4 2025 after selling out during the quarter.
  • CIBC Private Wealth Group sold 73 Clearside Biomedical shares in Q4 2025, an estimated $290.
  • CIBC Private Wealth Group first reported a position in Clearside Biomedical in Q1 2024 and held it in 7 quarters.
  • CIBC Private Wealth Group's Clearside Biomedical position peaked at $1.74K in Q1 2024.
  • 1 fund tracked by Wall St. Rank held Clearside Biomedical as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.